Ignite Creation Date:
2025-12-24 @ 3:18 PM
Ignite Modification Date:
2026-05-26 @ 12:16 PM
Study NCT ID:
NCT01746992
Status:
UNKNOWN
Last Update Posted:
2017-11-14
First Post:
2012-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
Sponsor:
Ruijin Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | ALK-negative Anaplastic Large Cell Lymphoma | View |
| None | Peripherial T Cell Lymphoma,Not Otherwise Specified | View |
| None | Angioimmunoblastic T Cell Lymphoma | View |
| None | Enteropathy Associated T Cell Lymphoma | View |
| None | Hepatosplenic T Cell Lymphoma | View |
| None | Subcutaneous Panniculitis Like T Cell Lymphoma | View |
Keywords: